Skip to main content

Advertisement

Log in

Using Technetium-99m Tetrofosmin Chest Imaging to Predict Taxol-Based Chemotherapy Response in Non-Small Cell Lung Cancer but Not Related to Lung Resistance Protein Expression

  • Published:
Lung Aims and scope Submit manuscript

Abstract

In vitro studies have shown that technetium-99m tetrofosmin (Tc-99m TF) is a transport substrate for the P-glycoprotein (Pgp) pump. Therefore, Tc-99m TF uptake of tumors can be used to predict chemotherapy response in lung cancers. However, whether lung resistance-related protein (LRP) expression affects tumor accumulation and efflux of Tc-99m TF in lung cancers is not known. Our aim was to use Tc-99m TF uptake of tumors to predict paclitaxel-based chemotherapy response of non-small cell lung cancer (NSCLC) and to compare Pgp or LRP expression. Twenty patients with advanced NSCLC received Tc-99m TF chest images before Taxol-based chemotherapy was used in this study. The chemotherapy response was evaluated by clinical and radiological methods in the third month after completion of treatment. No significant differences of prognostic factors (age, sex, body weight loss, performance status, tumor size, tumor stage, and tumor cell type) were found between the patients with good and those with poor responses. Early and delayed tumor/normal lung (T/L) uptake ratios were calculated on Tc-99m TF chest images. Immunohistochemical analyses were performed on multiple nonconsecutive sections of the biopsy specimens to detect Pgp and LPR expressions. The early and delayed T/L uptake ratios of 10 patients with good response were significantly higher than those of the other 10 patients with poor response. Significantly higher early and delayed T/L uptake ratios were found in patients with negative than those with positive Pgp expression (p < 0.05). However, no significant differences of early and delayed T/L uptake ratios were found between patients with negative and positive LRP expressions (p > 0.05). We found that Tc-99m TF imaging could accurately predict Taxol-base chemotherapy response. In addition, the Tc-99m TF tumor uptake was related to Pgp but not LPR expression in NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

Similar content being viewed by others

References

  1. S Akiyama ZS Chen M Kitazono T Sumizawa T Furukawa T Aikou (1999) ArticleTitleMechanisms for resistance to anticancer agents and the reversal of the resistance. Hum Cell 12 95–102 Occurrence Handle1:STN:280:DC%2BD3c7lvFegug%3D%3D Occurrence Handle10695015

    CAS  PubMed  Google Scholar 

  2. SH Cheng W Lam ASK Lee KP Fung RS Wu WF Fong (2000) ArticleTitleLow-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution. Toxicol Appl Pharmacol 164 134–142 Occurrence Handle10.1006/taap.2000.8903 Occurrence Handle1:CAS:528:DC%2BD3cXitl2qsL0%3D Occurrence Handle10764626

    Article  CAS  PubMed  Google Scholar 

  3. SP Cole G Bhardwaj JH Gerlach JE Mackie CE Grant KC Almquist AJ Stewart EU Kurz AM Duncan RG Deeley (1992) ArticleTitleOverexpression of a transporter gene in a multidrug-resistance human lung cancer cell line. Science 258 1650–1654

    Google Scholar 

  4. CL Crankshaw M Marmion GD Luker V Rao J Dahlheimer BD Burleigh E Webb KF Deutsch D Piwnica Worms (1998) ArticleTitleNovel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein. J Nucl Med 39 77–86 Occurrence Handle1:CAS:528:DyaK1cXnsFCksA%3D%3D Occurrence Handle9443741

    CAS  PubMed  Google Scholar 

  5. AMC Dingemans J van Ark-Otte P van der Valk RM Apolinario RJ Scheper PE Postmus G Giaccone (1996) ArticleTitleExpression of the human major vault protein LRP in human lung cancer samples and normal lung tissues. Ann Oncol 7 625–630 Occurrence Handle1:STN:280:ByiD3sznt1Q%3D Occurrence Handle8879378

    CAS  PubMed  Google Scholar 

  6. PA Francis MG Kris JR Rigas SC Grant VA Miller (1995) ArticleTitlePaclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer. Lung Cancer 12 S163–S172 Occurrence Handle10.1016/0169-5002(95)00432-Z Occurrence Handle7551925

    Article  PubMed  Google Scholar 

  7. LJ Goldstein (1996) ArticleTitleMDR1 gene expression in solid tumours. Eur J Cancer 32 1039–1050 Occurrence Handle10.1016/0959-8049(96)00100-1

    Article  Google Scholar 

  8. NH Hendrikse EJ Franssen WT van der Graaf W Vaalburg EG de Vries (1999) ArticleTitleVisualization of multidrug resistance in vivo. Eur J Nucl Med 26 283–293 Occurrence Handle10.1007/s002590050390 Occurrence Handle1:CAS:528:DyaK1MXht12ktb0%3D Occurrence Handle10079321

    Article  CAS  PubMed  Google Scholar 

  9. CF Higgins (1992) ArticleTitleABC transporters: from microorganisms to man. Annu Rev Cell Biol 8 67–113 Occurrence Handle1:CAS:528:DyaK3sXhvVSmuw%3D%3D Occurrence Handle1282354

    CAS  PubMed  Google Scholar 

  10. MA Izquierdo RH Shoemaker MJ Flens GL Scheffer L Wu TR Prather RJ Scheper (1996) ArticleTitleOverlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer 65 230–237

    Google Scholar 

  11. CH Kao JF Hsieh SC Tsai YJ Ho SP ChangLai JK Lee (2001) ArticleTitlePaclitaxel-based chemotherapy for non-small cell lung cancer: predicting the response with 99mTc-tetrofosmin chest imaging. J Nucl Med 42 17–20 Occurrence Handle1:CAS:528:DC%2BD3MXhtF2nsb8%3D Occurrence Handle11197970

    CAS  PubMed  Google Scholar 

  12. CH Kao JH Hsieh SC Tsai YJ Ho JK Lee (2000) ArticleTitleQuickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography. Clin Cancer Res 6 820–824 Occurrence Handle1:CAS:528:DC%2BD3cXisVaqt7c%3D Occurrence Handle10741702

    CAS  PubMed  Google Scholar 

  13. M Kitazono T Sumizawa Y Takebayashi ZS Chen T Furukawa S Nagayama A Tani S Takao T Aikou S Akiyama (1999) ArticleTitleMultidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 91 1647–1653 Occurrence Handle10.1093/jnci/91.19.1647 Occurrence Handle1:CAS:528:DyaK1MXmvVynurw%3D Occurrence Handle10511592

    Article  CAS  PubMed  Google Scholar 

  14. L Kostakoglu P Kiratli S Ruacan M Hayran S Emri EL Ergun CF Bekdik (1998) ArticleTitleAssociation of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. J Nucl Med 39 228–234 Occurrence Handle1:STN:280:DyaK1c7jsFOqsg%3D%3D Occurrence Handle9476923

    CAS  PubMed  Google Scholar 

  15. B Liu ED Staren T Iwamura HE Appert JM Howard (2001) ArticleTitleMechanisms of taxotere-related drug resistance in pancreatic carcinoma. J Surg Res 99 179–186 Occurrence Handle10.1006/jsre.2001.6126 Occurrence Handle1:CAS:528:DC%2BD3MXlsVSjsbk%3D Occurrence Handle11469885

    Article  CAS  PubMed  Google Scholar 

  16. MM Oken RH Creech DC Tormey J Horton TE Davis ET McFadden PP Carbone (1982) ArticleTitleToxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 649–655 Occurrence Handle1:STN:280:BiyC2cbntlU%3D Occurrence Handle7165009

    CAS  PubMed  Google Scholar 

  17. DM Paul DH Johnson (1995) Chemotherapy for non-small cell lung cancer. BE Johnson DH Johnson (Eds) Lung cancer. Wiley-Liss New York 247–261

    Google Scholar 

  18. GL Scheffer PL Wijngaard MJ Flens MA Izquierdo ML Slovak HM Pinedo CJ Meijer HC Clevers RJ Scheper (1995) ArticleTitleThe drug resistance-related protein LRP is the human major vault protein. Nat Med 6 578–582

    Google Scholar 

  19. RJ Scheper HJ Broxterman GL Scheffer et al. (1993) ArticleTitleOverexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 53 1457–1459

    Google Scholar 

  20. YC Shiau SC Tsai JJ Wang YJ Ho ST Ho CH Kao (2002) ArticleTitleTechnetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer. Lung 179 197–207 Occurrence Handle10.1007/s004080000061

    Article  Google Scholar 

  21. EF Smit PE Postmus (1995) Chemotherapy of non-small cell lung cancer. DN Carney (Eds) Lung cancer. The Bath Press London, UK 156–172

    Google Scholar 

  22. MJ Tabuenca JA Vargas A Varela C Salas A Durantez J Ortiz Berrocal (1998) ArticleTitleTechnetium-99m-tetrofosmin scintigraphy, P-glycoprotein and lung cancer. J Nucl Med 39 1830–1831 Occurrence Handle1:STN:280:DyaK1cvkslWqtg%3D%3D

    CAS  Google Scholar 

  23. J Zhou K Higashi Y Ueda Y Kodama D Guo F Jisaki (2001) ArticleTitleExpression of multidrug resistance protein and messenger rna correlate with 99mTc-MIBI imaging in patients with lung cancer. J Nucl Med 42 1476–1483 Occurrence Handle11585860

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Kao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shih, CM., Shiau, YC., Wang, JJ. et al. Using Technetium-99m Tetrofosmin Chest Imaging to Predict Taxol-Based Chemotherapy Response in Non-Small Cell Lung Cancer but Not Related to Lung Resistance Protein Expression . Lung 181, 103–111 (2003). https://doi.org/10.1007/s00408-003-1011-4

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-003-1011-4

Keywords

Navigation